Skip to main content
. 2022 Jan 6;12(1):e053667. doi: 10.1136/bmjopen-2021-053667

Table 3.

Summary of the results of the individual outcomes

Outcome variable No of study No of patients Incidence rate (%) Effect size
risk ratio (RR); (95% CI)
Heterogeneity test P value
Flap survival 8 2349 ICU=97.19 in
Non-ICU=97.89%
RR, 1.46; CI (0.80 to 2.69) 0% 0.231
Partial flap necrosis 2 880 ICU=1.98
Non-ICU=2.4
RR, 1.251; CI 0.321 to 4.876 0 0.747
Venous congestion 3 1097 ICU=2.90
Non-ICU=3.39
RR, 1.047; CI 0.486 to 2.257 0 0.906
Arterial thrombosis 3 1097 ICU=1.01
Non-ICU=1.97
RR, 0.804; CI 0.261 to 2.471 0 0.703
Reoperation 5 1253 ICU=12.34%
Non-ICU=9.44%
RR, 1.327; CI 0.693 to 2.539 53% 0.394
Readmission 4 861 ICU=10.91%
Non-ICU=8.95%
0.922; 95% CI 0.611 to 1.392 0 0.700
Pneumonia 4 1203 ICU=6.87
Non-ICU=2.45
RR, 2.769; CI 1.193 to 6.424 0 0.018
Respiratory failure 3 1027 ICU=11.33
Non-ICU=6.09
RR, 1.675; CI 0.911 to 3.078 35% 0.097
Need for ventilation 2 365 ICU=12.5
Non-ICU=10.52
RR, 1.926; CI 1.128 to 3.288 0 0.016
Sepsis 5 1462 ICU=1.6
Non-ICU=0
RR, 4.23; CI 1.12 to 15.91 0 0.033
Delirium 2 365 ICU=12.5
Non-ICU=6.02
RR, 2.067; CI 0.944 to 44.526 0 0.069
Mortality 3 1115 ICU=0.38
Non-ICU=0.32
RR, 0.633; CI 0.072 to 5.532 0 0.679

ICU, intensive care unit.